GeoVax is a company to watch in the biotechnology industry. Their innovative approach to vaccine development is making a real impact. #COVID19#vaccine#biotechnology https://t.co/WAHupLOnbA
$GOVX to Present at the Noble Capital Markets Emerging Growth Equity Conference December 3, 2024. Video webcast available the following day on https://t.co/m2JBuVqdV5 #mpox#immunocompromised#mva
GeoVax's Phase 2 trial interim review forCOVID-19 booster vaccine in chronic lymphocytic leukemia patients supports continued enrollment. While the mRNA control arm failed to meet primary endpoint, GEO-CM04S1 shows promise for immunocompromised patients. https://t.co/9Vtsnunlkm
We want to welcome @Geovax_News to the @ROTHCapital Partners 3rd Annual Healthcare Opportunities Conference October 9th. See their profile on @B2iDigital at https://t.co/5MsVsQ9rvX
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing vaccines and immunotherapies against infectious diseases and cancers using novel proprietary platforms. GeoVax’s product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and therapy for advanced head and neck cancer. Additional development programs include preventive vaccines against Mpox and smallpox, hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, and Marburg), malaria and Zika virus, as well as therapies for various solid tumors. (Source: Company Website 08.06.24)
We look forward to seeing the continued results from David A. Dodd, Arban Domi, Mary Hauser, Susan Hensley, MS, RAC, Kelly McKee, Mark Newman, John Niles, Tom O'Brien, Sreenivasa Rao Oruganti, J. Marc Pipas, MD, Erica Raiden, Mark Reynolds, John W. Sharkey, Jeff Welch, Ashley Zuniga, PhD PMP and the entire GeoVax Labs, Inc. team!
Thanks to the stellar team at ROTH for organizing this conference: Sagar Sheth, Byron Roth, Isabel Mattson-Pain, Amanda McAdams, Otilia "Charo" Montano, Benjamin Bowen, James Antonopoulos, Jason Wittes, Jonathan Aschoff, Ph.D., Boobalan Pachaiyappan, Ph.D. and many others
ROTH is a relationship-driven investment bank headquartered in Newport Beach, CA. For more information on ROTH, please visit https://t.co/f7LaejqxRB.
We hope you’ll be able to attend this pivotal event shaping the future of healthcare innovation.
Have a question about the state of an #Mpoxvaccine ? $GOVX GeoVax Labs to Present at the Emerging Growth Conference on August 21, 2024
[email protected]
Innovators & Investors Come Together to Shape the Future of Healthcare. #biotech, #demy-colton, #innovators, #disruptors Learn more and register here. https://t.co/Eb6vTb3X6x
Vaccinations have begun in an investigator-initiated clinical trial of GEO-CM04S1 in patients with chronic lymphocytic leukemia (CLL) #vaccines#leukemia $GOVX
https://t.co/dAuZpjQfqa
I am speaking at Entrepreneur & Investor Life Science Summit 2023. Please check out my talk if you're attending the event! #eisummit - via #Whova event app